Int J Sports Med 2012; 33(03): 171-176
DOI: 10.1055/s-0031-1285930
Physiology & Biochemistry
© Georg Thieme Verlag KG Stuttgart · New York

Cardiac Markers of EIH Athletes in Ultramarathon

Y.-J. Kim
1   Inje University, Department of Rehabilitation Medicine, Seoul, Republic of Korea
,
C.-H. Kim
2   Korea National Sport University, Exercise Physiology and Biochemistry, Seoul, Republic of Korea
,
K.-A. Shin
3   Bun-dong Je-Saeng Hospital, Laboratory Medicine, Kyunggi-do, Republic of Korea
,
A.-C. Kim
4   Korea National Sport University, Sports Medicine, Seoul, Republic of Korea
,
Y.-H. Lee
5   Korea National Sport University, Physiology, Seoul, Republic of Korea
,
C.-W. Goh
6   Sanggye-Paik Hospital, Inje University, Cardiology, Seoul, Republic of Korea
,
J.-K. Oh
4   Korea National Sport University, Sports Medicine, Seoul, Republic of Korea
,
H.-S. Nam
7   Kangdong Sacred Heart Hospital, Rehabilitation Medicine, Seoul, Republic of Korea
,
Y. Park
8   Sanggye Paik Hospital, Rehabilitation Medicine, Seoul, Republic of Korea
› Author Affiliations
Further Information

Publication History



accepted after revision 11 July 2011

Publication Date:
19 January 2012 (online)

Abstract

This study aimed to investigate effects of a 100-km ultramarathon on cardiac markers of exercise-induced-hypertensive marathoners. 10 marathoners with exercise-induced hypertension and 10 normal marathoners participated in the study. Their blood samples were collected before starting, at 50 km, and after finishing the course (100 km). Creatinine kinase was more significantly increased in the exercise-induced-hypertensive group than in the normal group at 100 km (P<0.05). N-terminal pro-brain nutriuretic peptide was significantly increased in the exercise-induced-hypertensive group at 50 km and 100 km (P<0.05) which was significant being doubled compared to the normal group (P<0.05). Exercise-induced-hypertensive marathoners showed a significant triple-increase in C-Reactive protein at 100 km (P<0.05). In conclusion, although the exercise-induced-hypertensive runners did not have myocardial damage during the 100 km ultramarathon, they had higher myocardial stress and more damage in active muscles due to a bloodstream disability.

 
  • References

  • 1 Adams JE, Bodor GS, Dávila-Román VG, Delmez JA, Apple FS, Ladenson SA, Jaffe AS. Cardiac troponin I: A marker with high specificity for cardiac injury. Circulation 1993; 88: 101-106
  • 2 Avolio AP, Deng FQ, Li WQ, Luo YF, Huang ZD, Xing LF, ORourke MF. Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. Circulation 1985; 71: 202-210
  • 3 Blake GA, Levin SR, Koyal SN. Exercise-induced hypertension in normotensive patients with IDDM. Diabetes Care 1990; 13: 799-801
  • 4 Chang HJ, Chung J, Choi SY, Yoon MH, Hwang GS, Shin JH, Tahk SJ, Choi BI. Endothelial dysfunction in patients with exaggerated blood pressure response during treadmill test. Clin Cardiol 2004; 27: 421-425
  • 5 Clarkson PM. Exertional rhabdomyolysis and acute renal failure in marathon runners. Sports Med 2007; 37: 361-363
  • 6 Fortescue EB, Shin AY, Greenes DS, Mannix RC, Agarwal S, Feldman BJ, Shah MI, Rifai N, Landzberg MJ, Newburger JW, Almond CS. Cardiac troponin increases among runners in the Boston Marathon. Ann Emerg Med 2007; 49: 137-143
  • 7 Harriss DJ, Atkinson G. Update – Ethical Standards in Sport and Exercise Science Research. Int J Sports Med 2011; 32: 819-821
  • 8 Herrmann M, Scharhag J, Miclea M, Urhausen A, Herrmann W, Kindermann W. Post-race kinetics of cardiac troponin T and I and N-terminal pro-brain natriuretic peptide in marathon runners. Clin Chem 2003; 49: 831-834
  • 9 Kim HJ, Lee YH, Kim CK. Changes in serum cartilage oligomeric matrix protein (COMP), plasma CPK and plasma hs-CRP in relation to running distance in a marathon (42.195 km) and an ultra-marathon (200 km) race. Eur J Appl Physiol 2009; 105: 765-770
  • 10 Kurl S, Laukkanen JA, Rauramaa R, Lakka TA, Sivenius J, Salonen JT. Systolic blood pressure response to exercise stress test and risk of stroke. Stroke 2001; 32: 2036-2041
  • 11 La Gerche A, Boyle A, Wilson A, Prior D. No evidence of sustained myocardial injury following an Ironman distance triathlon. Int J Sports Med 2004; 25: 45-49
  • 12 Lauer MS, Levy D, Anderson KM, Plehn JF. Is there a relationship between exercise systolic blood pressure response and left ventricular mass? The Framingham Heart Study. Ann Intern Med 1992; 116: 203-210
  • 13 Maron BJ, Poliac LC, Roberts WO. Risk for sudden cardiac associated with marathon running. J Am Coll Cardiol 1996; 28: 428-431
  • 14 Mittleman MA, Maclure M, Tofler GH, Sherwood JB, Goldberg RJ, Muller JE. Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of Myocardial Infarction Onset Study Investigators. N Engl J Med 1993; 329: 1677-1683
  • 15 Mora S, Cook N, Buring JE, Ridker PM, Lee IM. Physical activity and reduced risk of cardiovascular events. Potential mediating mechanisms. Circulation 2007; 116: 2110-2118
  • 16 Mundal R, Kjeldsen SE, Sandvik L, Erikssen G, Thaulow E, Erikssen J. Exercise blood pressure predicts mortality from myocardial infarction. Hypertension 1996; 27: 324-329
  • 17 Neumayr G, Pfister R, Mitterbauer G, Eibl G, Hoertnagl H. Effect of competitive marathon cycling on plasma N-terminal pro-brain natriuretic peptide and cardiac troponin T in healthy recreational cyclists. Am J Cardiol 2005; 96: 732-735
  • 18 Pearson JR, Carrea F. Evaluation of the clinical usefulness of a chemiluminometric method for measuring creatine kinase MB. Clin Chem 1990; 36: 1809-1811
  • 19 Richards AM, Nicholls MG, Yandle TG, Frampton C, Espiner EA, Turner JG, Buttimore RC, Lainchbury JG, Elliott JM, Ikram H, Crozier IG, Smyth DW. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998; 97: 1921-1929
  • 20 Scharhag J, George K, Shave R, Urhausen A, Kindermann W. Exercise-associated increases in cardiac biomarkers. Med Sci Sports Exerc 2008; 40: 1408-1415
  • 21 Scharhag J, Herrmann M, Urhausen A, Haschke M, Herrmann W, Kindermann W. Independent elevations of N-terminal pro-brain natriuretic peptide and cardiac troponins in endurance athletes after prolonged strenuous exercise. Am Heart J 2005; 150: 1128-1134
  • 22 Scott JM, Esch BT, Shave R, Warburton E, Gaze D, George K. Cardiovascular consequences of completing a 160-km ultramarathon. Med Sci Sports Exerc 2009; 41: 26-34
  • 23 Shim CY, Ha JW, Park S, Choi EY, Choi D, Rim SJ, Chung N. Exaggerated blood pressure response to exercise is associated with augmented rise of angiotensin II during exercise. J Am Coll Cardiol 2008; 52: 287-292
  • 24 Siegel AJ. Relative risk of sudden cardiac death during marathon running. Arch Intern Med 1997; 157: 1269-1270
  • 25 Singh JP, Larson MG, Manolio TA, ODonnell CJ, Lauer M, Evans JC, Levy D. Blood pressure response during treadmill testing as a risk factor for new-onset hypertension. The Framingham Heart Study. Circulation 1999; 99: 1831-1836
  • 26 Stewart KJ, Sung J, Silber HA, Fleg JL, Kelemen MD, Turner KL, Bacher AC, Dobrosielski DA, DeRegis JR, Shapiro EP, Ouyang P. Exaggerated exercise blood pressure is related to impaired endothelial vasodilator function. Am J Hypertension 2004; 17: 314-320
  • 27 Taddei S, Virdis A, Mattei P, Arzilli F, Salvetti A. Endothelial dependent forearm vasodilation is reduced in normotensive subjects with familial history of hypertension. J Cardiovasc Pharmacol 1992; 20: S193-S195
  • 28 Thygesen K, Alpert JS, White HD. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Kardiol Pol 2008; 66: 47-61
  • 29 Wilson MF, Sung BH, Pincomb GA, Lovallo WR. Exaggerated pressure response to exercise in men at risk for systemic hypertension. Am J Cardiol 1990; 66: 731-736
  • 30 Zhang X, Zhao SP, Li XP, Gao M, Zhou QC. Endothelium dependent and independent functions are impaired in patients with coronary heart disease. Atherosclerosis 2000; 149: 19-24